ShahA, MorrisonM, BurgerD, . Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther2019;49:624–35.doi:10.1111/apt.15133http://www.ncbi.nlm.nih.gov/pubmed/30735254
2.
PetersenC, RoundJL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol2014;16:1024–33.doi:10.1111/cmi.12308http://www.ncbi.nlm.nih.gov/pubmed/24798552
ShahA, TalleyNJ, JonesM, . Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. Am J Gastroenterol2020;115:190–201.doi:10.14309/ajg.0000000000000504http://www.ncbi.nlm.nih.gov/pubmed/31913194
5.
HoltmannG, ShahA, MorrisonM. Pathophysiology of functional gastrointestinal disorders: a holistic overview. Dig Dis2017;35 Suppl 1:5–13.doi:10.1159/000485409http://www.ncbi.nlm.nih.gov/pubmed/29421808
6.
SoD, WhelanK, RossiM, . Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr2018;107:965–83.doi:10.1093/ajcn/nqy041http://www.ncbi.nlm.nih.gov/pubmed/29757343
VandeputteD, FalonyG, Vieira-SilvaS, . Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut2016;65:57–62.doi:10.1136/gutjnl-2015-309618http://www.ncbi.nlm.nih.gov/pubmed/26069274
9.
VandeputteD, KathagenG, D'hoeK, . Quantitative microbiome profiling links gut community variation to microbial load. Nature2017;551:507–11.doi:10.1038/nature24460http://www.ncbi.nlm.nih.gov/pubmed/29143816
10.
GeversD, KugathasanS, DensonLA, . The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe2014;15:382–92.doi:10.1016/j.chom.2014.02.005http://www.ncbi.nlm.nih.gov/pubmed/24629344
11.
ShahA, MorrisonM, HoltmannGJ. Gastroduodenal “Dysbiosis”: a New Clinical Entity. Curr Treat Options Gastroenterol2018;16:591–604.doi:10.1007/s11938-018-0207-xhttp://www.ncbi.nlm.nih.gov/pubmed/30421297
12.
CervantesJ, MichaelJ, HongB. Investigation of oral, gastric, and duodenal microbiota in patients with upper gastrointestinal symptoms. J Investig Med2021;69:870–7.doi:10.1136/jim-2020-001642
13.
YuG, FadroshD, GoedertJJ, . Nested PCR biases in interpreting microbial community structure in 16S rRNA gene sequence datasets. PLoS One2015;10:e0132253. doi:10.1371/journal.pone.0132253http://www.ncbi.nlm.nih.gov/pubmed/26196512
14.
GurusamySR, ShahA, TalleyNJ, . Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol2021. doi:doi:10.14309/ajg.0000000000001197. [Epub ahead of print: 16 Mar 2021].http://www.ncbi.nlm.nih.gov/pubmed/33734110
15.
ShahA, KangS, TysonG, . Su1204 variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease. Gastroenterology2020;158:S-542. doi:10.1016/S0016-5085(20)32052-7
16.
ShanahanER, ZhongL, TalleyNJ, . Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures. Aliment Pharmacol Ther2016;43:1186–96.doi:10.1111/apt.13622http://www.ncbi.nlm.nih.gov/pubmed/27086880
17.
ShahA, TalleyNJ, KoloskiN, . Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Aliment Pharmacol Ther2020;52:155–67.doi:10.1111/apt.15786http://www.ncbi.nlm.nih.gov/pubmed/32412673
18.
ZhongL, ShanahanER, RajA, . Dyspepsia and the microbiome: time to focus on the small intestine. Gut2017;66:1168–9.doi:10.1136/gutjnl-2016-312574http://www.ncbi.nlm.nih.gov/pubmed/27489239
19.
ElsenbruchS, LucasA, HoltmannG, . Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol2006;101:2300–7.doi:10.1111/j.1572-0241.2006.00837.xhttp://www.ncbi.nlm.nih.gov/pubmed/16952284
20.
LiebregtsT, AdamB, BredackC, . Immune activation in patients with irritable bowel syndrome. Gastroenterology2007;132:913–20.doi:10.1053/j.gastro.2007.01.046http://www.ncbi.nlm.nih.gov/pubmed/17383420
21.
MargolisKG, CryanJF, MayerEA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology2021. doi:doi:10.1053/j.gastro.2020.10.066. [Epub ahead of print: 22 Jan 2021].http://www.ncbi.nlm.nih.gov/pubmed/33493503
